Three Medicare payment rules are in motion right now, and this week one of them stopped moving. On August 4, 2026, CMS issued the FY 2027 Hospital Inpatient Prospective Payment System and Long-Term Care Hospital PPS final rule (CMS-1849-F), effective October 1, 2026. It is the first finalized rate of the CY 2027 rulemaking cycle — and for physician practices that never bill an inpatient claim, it still matters, because it sets the market-basket anchor that commercial contract escalators, hospital employment offers, and health-system acquisition math all key off of.
| Metric | FY 2027 Final |
|---|---|
| IPPS operating payment update | +2.3% |
| Hospital market basket increase | +3.2% |
| Productivity adjustment | −0.9 percentage points |
| Net additional payments to hospitals | +$2.1 billion |
| New technology add-on payments (NTAP) | +$779 million |
| Effective date | October 1, 2026 |
The 2.3% update applies only to hospitals that successfully participate in the Hospital Inpatient Quality Reporting (IQR) program and are meaningful EHR users. CMS adopted three new IQR measures and removed three, and updated data submission requirements for several measures including the Maternal Morbidity Structural Measure.
CMS also finalized updates to the Transforming Episode Accountability Model (TEAM), expanding eligible spinal fusion episodes, realigning attribution and quality measures with other CMS programs, and refining target-price construction. If your surgeons operate at a TEAM hospital, the episode economics they are being measured against changed on August 4.
The contrast is the story. Hospitals get +2.3% and $2.1 billion. Physicians are staring at a proposed −1.68% conversion factor cut for the same period. That is not a rounding difference — it is roughly a four-point swing in the same fiscal year, in the same program, for care that increasingly moves between the two settings.
| Rule | Content | Deadline | Days Left |
|---|---|---|---|
| CMS-1850-P CY 2027 OPPS/ASC | +2.4% OPPS/ASC update; 340B moves from ASP+6% to ASP−33.4%; site-neutral extended to non-contrast imaging in excepted off-campus PBDs; IPO list phase-out | August 31, 2026 | 17 days |
| CMS-1846-P CY 2027 PFS | Conversion factors $33.1693 / $32.8409; 50% modifier 25 reduction; 2.5% efficiency adjustment; IPCI phase-out with ±5% PE stabilizer | September 14, 2026 | 31 days |
The 340B proposal is the largest single dollar movement in either rule. CMS proposes to pay for 340B-acquired drugs at ASP minus 33.4% instead of the general OPPS methodology of ASP plus 6% — an approximately 37% reduction in reimbursement, based on the Medicare OPPS drug acquisition cost survey run from January 1 through April 7, 2026. Independent oncology and infusion practices competing against 340B-advantaged hospital outpatient departments should read this as a partial narrowing of a spread that has driven a decade of oncology consolidation.
The OPPS comment window closes August 31 and the PFS window closes September 14. If your practice performs imaging in an off-campus provider-based department, infuses 340B drugs, or bills anything on the inpatient-only list, both letters need to be written in the next two weeks. Comment volume demonstrably moves CMS on site-of-service policy — the CY 2026 340B remedy was not finalized precisely because the comment record pushed CMS to survey acquisition cost first.
The AHIP voluntary commitment framework has moved from announcement to operating reality. Forty-eight health insurers covering 257 million Americans across Medicare Advantage, Medicaid, and commercial lines pledged to streamline, simplify, and reduce prior authorization. The first tranche took effect January 1, 2026 — reducing the scope of claims subject to PA at all.
What is coming: In 2027, at least 80% of electronic prior authorization approvals submitted with complete clinical documentation must be answered in real time. That is the provision that will actually change front-office staffing models — and it only fires for requests that arrive electronically with complete clinicals. Practices still faxing will get none of it.
Plans are introducing or expanding gold carding for high-volume services — imaging, cardiology, radiology, select outpatient procedures, and medications. UnitedHealthcare reports its Gold Card program cut authorization volume by an average of 30% for eligible provider groups in 2025.
That is a hard number worth chasing. A 30% reduction in PA volume for a practice submitting 400 authorizations a month is 120 fewer submissions — at industry-typical handling cost, real FTE capacity returned to the front desk.
CMS is piloting the same idea inside Traditional Medicare. The WISeR (Wasteful and Inappropriate Service Reduction) model intends to pilot a gold carding feature by mid-2026, exempting clinicians with consistent approval histories from future PA requirements on model services.
On July 16, 2026, the U.S. Senate voted 46 to 50 against an effort to overturn WISeR. The model continues through its planned end date of December 31, 2031. It covers 17 outpatient services in six states — Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington — affecting roughly 6.4 million Traditional Medicare beneficiaries. Providers choose between submitting a prior authorization request or accepting post-service, pre-payment review. Decisions are expected within 72 hours (48 for expedited).
Health systems deploying AI for prior authorization reported a 22% decrease in authorization-related denials from commercial payers and an 18% decrease in denials for services deemed not covered. The 7-day/72-hour clock only helps if your submission is complete on the first pass — the payer’s timer does not start on an incomplete request. Automation that validates clinical attachments before submission is what converts a regulatory deadline into cash.
For three years ambient documentation has been sold on burnout relief. In 2026 the operating data finally includes revenue.
| Metric | Result | Source |
|---|---|---|
| Documentation time reduction | 20–40% | Aggregated 2026 deployment studies |
| Hours saved in one year | 15,791 (≈1,800 workdays) | The Permanente Medical Group |
| After-hours documentation | −35% | St. Luke’s |
| Patient face time | +15% | St. Luke’s |
| Annual revenue per clinician | $13,049 | St. Luke’s |
| Note completeness, ambient audio alone | 40.4 / 100 | 2025 study, 354 primary care encounters |
That last row is the one to internalize. A note that reads beautifully and scores 40.4 out of 100 on completeness is a downcoding exposure, not a productivity win. Ambient output that is not reconciled against the elements required to support the billed level of service produces clean-looking documentation that will not survive an audit or a payer’s algorithmic level-of-service review. The organizations reporting revenue gains are the ones that routed ambient output into a coding validation layer — not the ones that pointed it at the chart and walked away.
Where organizations are pointing it: 57% prioritize denial management and appeals, 56% prioritize documentation and coding accuracy, and 67% expect AI and automation to have the largest impact on denials and underpayment management.
| Barrier | Share Citing |
|---|---|
| IT infrastructure limitations | 51% |
| Lack of budget | 44% |
| Integration with existing systems | 43% |
| Difficulty demonstrating ROI | 42% |
| Vendor reliability concerns | 42% |
Note that four of the five are not about the AI. They are about the plumbing it has to run through. A practice with a clean HL7/FHIR path between EHR, clearinghouse, and PM system will get value from tools that a practice with three unreconciled systems will not — from the identical contract.
The counterexample worth citing to your board: Experian Health’s AI Advantage customers — using Predictive Denials and Denial Triage — report an average denial rate of 4%, against an industry average north of 10%. And 41% of providers now run denial rates of 10% or higher, up from 30% in 2022, while only 14% report using AI to reduce denials. The highest-value use case remains the least automated.
Before buying another AI module, run a 30-day audit of ambient-generated notes against the level of service billed. If your ambient tool is producing notes that support 99213 while the encounter warranted 99214, you are funding your own downcoding. Fix the coding validation layer first; it is cheaper than the module and it is where the $13,049 per clinician actually comes from.
FY 2027 ICD-10-CM is posted and effective October 1, 2026 — 48 days from today. It applies to discharges and patient encounters from October 1, 2026 through September 30, 2027.
CMS’s posted files carry 238 new codes, 4 revised, and 21 deleted. Several downstream analyses count the update at 190 new / 30 deleted / 4 revised depending on whether expansions within existing categories are counted as new codes or category revisions — either way the update spans 33 clinical topics across nearly every chapter.
Telehealth flexibilities themselves are safe — the Consolidated Appropriations Act of 2026 (H.R. 7148), signed February 3, 2026, extends geographic and originating-site flexibilities through December 31, 2027. Patients may continue receiving telehealth at home regardless of rural status.
But one billing mechanism does not ride along. Rural health clinics and FQHCs may continue billing HCPCS G2025 for non-behavioral-health telehealth only through December 31, 2026 — 139 days from today.
Also worth confirming in your fee schedule build: CMS declined to reimburse most of the AMA’s dedicated telehealth E/M series 98000–98016, holding that the codes duplicate existing E/M with modifiers. Medicare requires standard office visit codes 99202–99215 with the appropriate place-of-service code and modifier. The single exception CMS pays is 98016, the virtual check-in code, which replaced HCPCS G2012.
Practices that loaded the 98000–98016 series into their charge master on the assumption Medicare would pay them are generating denials right now. Audit your telehealth charge lines against the 99202–99215-plus-modifier convention before the FY 2027 code load compounds the problem.
The 2026 patient-collections data contains a genuine structural shift, and it is not subtle.
| Metric | 2025 | 2026 | Direction |
|---|---|---|---|
| Share of total patient billings collected | 24% | 31% | ▲ +7 pts |
| Pre-service share of self-pay collections | 16% | 21% | ▲ +5 pts |
| Collecting/requiring payment or card-on-file at estimate | 81.3% | 91.5% | ▲ +10.2 pts |
| Patient collections tied up in open payment plans | 30% | 23% | ▼ −7 pts |
Meanwhile, the back end deteriorated: the self-pay-after-insurance collection rate fell 5.2% year over year to 29% in February, and point-of-service cash collections were 24.4% of total patient payments, up only 0.8% year over year per Kodiak tracking.
Read those two blocks together and the conclusion is unambiguous. Money collected before or at the point of service is compounding. Money chased after adjudication is decaying. The 7-point jump in total collection rate did not come from better collections calls; it came from 91.5% of organizations putting a payment method on file during the estimate conversation.
Supporting pressure: average deductibles reached $1,886, up 17%; 71% of providers cite patient financial responsibility as a top concern; bad debt from patient balances runs 3–5% of net patient revenue at the median practice; and 73% of consumers prefer to pay medical bills online. Practices deploying patient-led check-in kiosks report a 154% increase in time-of-service collections on 96% patient adoption.
| KPI | Industry Benchmark | Where You Should Be | Warning Threshold |
|---|---|---|---|
| Days in A/R | 30–40 days (HFMA) | < 35 days | > 45 days |
| Clean claim rate | 95% typical | 98% (HFMA target) | < 92% |
| Cost to collect | 2–4% of net patient revenue | ≤ 3% | > 5% |
| First-pass resolution rate | 85–90% | ≥ 95% | < 85% |
| Initial denial rate | 11.8% industry; 41% sit above 10% | < 5% | > 10% |
| Point-of-service collection rate | 24.4% of patient payments | ≥ 35% | < 20% |
| Pre-service share of self-pay collections | 21% | ≥ 30% | < 15% |
| Bad debt as % of net patient revenue | 3–5% | ≤ 3% | > 6% |
| Payment method on file at estimate | 91.5% | 100% | < 80% |
| A/R over 90 days | 15–20% | < 12% | > 25% |
63% of healthcare providers report staffing gaps in their RCM departments per AAPC, and RCM turnover averages nearly 20%. More than half of revenue cycle leaders say they expect their operations to become less effective unless they change something quickly. 97% of healthcare organizations now outsource at least one RCM function, and 70% plan to expand outsourcing in the coming year.
This is why front-end automation outperforms back-end hiring. You cannot staff your way out of a 20% turnover rate. You can, however, eliminate the work: 60% of providers cite front-end processes like eligibility as a top cause of denials, and eligibility verification is the single most automatable transaction in the entire cycle.
The practices posting a 31% patient collection rate are not better at collections. They are better at timing. Every dollar of patient responsibility that moves from post-adjudication statement to pre-service card-on-file collects at roughly triple the yield and at a fraction of the cost to collect. Move the conversation forward in the visit; the yield follows automatically.
Black Book Research released its 2026 State of Health & Hospital Systems Revenue Cycle Management Technology & Services report, naming top client-rated vendors across 49 RCM categories and profiling 420 vendors. The methodology is worth noting because it is client-rated rather than analyst-scored: 1,300+ validated provider-side participants surveyed October 2025 through June 2026, evaluated across 18 qualitative KPIs per category for 720 total measures.
| Category | Top Client-Rated Vendor |
|---|---|
| Full provider cloud RCM suite | Inovalon |
| RCM-native agentic AI | Waystar |
| Workflow orchestration | Notable |
| Denial prevention | AKASA |
| Prior authorization automation | Infinx |
| Digital scheduling | Luma Health |
| Patient access and registration | RevSpring True Access |
PitchBook’s Q2 2026 report — bluntly titled AI Kills the RCM Star — warns private equity to be wary of RCM deals because agentic AI is gutting take rates. RCM has absorbed $42.9 billion in PE deals since 2017, including a recently announced $12 billion acquisition of Ensemble Health Partners. PitchBook expects 3–5 acquisitions in the next 12 months, primarily large RCM platforms absorbing point solutions, with prior auth and denial management identified as overbuilt categories.
Translation for a practice buying RCM services: the percentage-of-collections model is under structural pressure. If your billing company charges 5–7% of collections and its own cost to deliver is collapsing because of automation it did not build, you have leverage in your next renewal that you did not have eighteen months ago. Ask what portion of your claims are now touched by autonomous processing, and price accordingly.
On May 28, 2026, HHS, DOL, Treasury, and OPM finalized operational changes to the federal independent dispute resolution (IDR) process under the No Surprises Act, published in the Federal Register on June 4, 2026. The single most consequential provision for independent practices:
The administrative fee dropped from $115 to $15 per party, per dispute, for disputes initiated on or after June 11, 2026 — an 87% reduction.
That changes the arithmetic of out-of-network arbitration completely. At $115 per party, a disputed $400 out-of-network claim was economically irrational to arbitrate. At $15, it is not. Practices that wrote off small-dollar out-of-network balances as unrecoverable should re-run that model against the new fee schedule and the new batching rules.
The rest of the final rule standardizes communications, clarifies timelines, updates batching criteria, and creates a new payor registry and centralized IDR infrastructure — all aimed at the volume problem. And the volume is extraordinary: 6,336,032 disputes initiated between April 15, 2022 and May 31, 2026. The backlog has largely cleared — between December 1, 2025 and January 31, 2026, closures (506,242) nearly matched initiations (516,241).
Enforcement of the new and updated Hospital Price Transparency requirements has been live since April 1, 2026. Separately, CMS’s open proposal on machine-readable file standardization takes comments through August 31, 2026, at 11:59 PM EDT — the same deadline as the OPPS rule.
TEFCA volume has gone vertical: from roughly 10 million records exchanged in January 2025, past 500 million by February 2026, to more than 1 billion today. ONC has awarded a multiyear contract to audit QHIN compliance and has expanded participant reviews.
Enforcement is real. In March 2026, the U.S. District Court for the Central District of California permanently enjoined GuardDog Telehealth from requesting records through TEFCA or Carequality after the company allegedly obtained thousands of patient records by falsely asserting treatment purpose. If your practice queries a network, your stated purpose of use is now an auditable legal assertion — not a dropdown.
ONC also intends to finalize HTI-5 deregulatory changes in August 2026, following the December 29, 2025 proposal.
Under the One Big Beautiful Bill Act, certain Medicaid expansion enrollees must complete 80 hours of qualifying monthly activities beginning January 1, 2027. States must use existing data systems to verify compliance where possible. Self-attestation is permitted only in 2027; beginning January 1, 2028, states must generally require documentation where reliable data is unavailable.
Projections put coverage losses at up to 5.2 million beneficiaries by 2034, driven largely by administrative barriers rather than actual ineligibility. For a practice, that translates directly into churned eligibility, mid-treatment coverage terminations, and uncompensated care. Real-time eligibility verification at every visit — not at registration only — stops being a nice-to-have on January 1.
Two things go on the calendar today. First: re-run your out-of-network write-off model against the $15 IDR fee — claims you abandoned at $115 may now be worth batching. Second: if you serve Medicaid expansion patients, move eligibility verification from a registration-only check to an every-encounter check before January 1, 2027.
The PAI-Avalere Health study of physician employment trends covering January 2018 through January 2026 puts the number beyond argument.
Regional detail matters for anyone modeling a local market: over the eight-year window, non-independent physicians grew between 66.1% (Midwest) and 106.7% (South), and non-physician-owned practices grew between 86.4% (Midwest) and 140.2% (South).
| Development | Health System | Independent Practice |
|---|---|---|
| FY 2027 IPPS final: +2.3%, +$2.1B | Locked-in rate increase effective Oct 1 | No corresponding update; faces proposed −1.68% CF |
| 340B ASP−33.4% proposal | Narrows a major margin advantage | Partially levels the infusion/oncology playing field |
| Site-neutral for non-contrast imaging | Reduces the PBD premium | Reduces the acquisition premium a system will pay for your imaging |
| Modifier 25 50% reduction | Absorbed across a diversified system | Direct, uncushioned revenue hit on procedural visits |
| $15 IDR fee | Legal department already staffed | First time small-dollar arbitration is economically rational |
| 7-day / 72-hour PA clocks | Dedicated PA teams already built | Requires automation, not headcount, to capture the benefit |
| Medicaid work requirements (Jan 1, 2027) | Uncompensated care pools, DSH | No cushion — churned eligibility hits cash directly |
There is a genuine two-sided story this week. Site-neutral policy and the 340B repricing both cut against the hospital arbitrage that has fueled acquisition — the first meaningful federal narrowing of that spread in years. Independents lose on the conversion factor and modifier 25; they gain on the payment-differential rules. Whether the net favors independence depends heavily on procedural mix.
| Metric | Typical Independent Practice | Where You Should Be |
|---|---|---|
| Days in A/R | 42–50 days | < 35 days |
| Clean claim rate | 88–92% | ≥ 97% |
| Initial denial rate | 10–12% | < 5% |
| Cost to collect | 5–7% of collections | ≤ 4% |
| Eligibility verified pre-visit | 60–70% | 100%, automated |
| Point-of-service collection rate | 15–20% | ≥ 30% |
| Payment method on file at estimate | Ad hoc | 100% of scheduled visits |
| RCM staff turnover | ~20% | < 12% |
| Denials worked within 7 days | 45–55% | ≥ 90% |
| Out-of-network balances arbitrated | Near zero | Batch monthly at the $15 fee |
With 63% of providers reporting RCM staffing gaps and turnover near 20%, independent practices cannot close these benchmark gaps with hiring. The only path from a 42-day A/R to a 35-day A/R at a five-physician practice runs through eliminating manual eligibility, manual claim status, and manual payment posting — the three highest-volume, lowest-judgment tasks in the cycle.
| Specialty | This Week’s Development | The Number | What To Do |
|---|---|---|---|
| Primary Care | APCM is the clearest revenue-positive story in the fee schedule. CMS finalized ~10% increases across all three codes for 2026 and added three behavioral health add-ons (G0568, G0569, G0570) letting practices layer CoCM and BHI on top of APCM for the first time. G2211 converts to a 16% modifier in 2027 (32% in MSSP ACOs and LEAD). | G0556 $16.30 G0557 $53.50 G0558 $116.00 per patient per month |
Enroll eligible Medicare patients; verify the 13 service elements are documented; watch the CCM/PCM/TCM concurrent-billing prohibition |
| Cardiology | Cardiovascular services land at roughly +1% overall for CY 2027 — a win relative to the field, but the 2.5% efficiency adjustment still applies to procedural and diagnostic codes. | ~+1% overall CY 2027 | Model the efficiency adjustment separately from the specialty impact table; they net differently by code mix |
| Orthopedics | The worst-positioned specialty in the CY 2027 proposal: −7% overall, the only specialty whose overall impact includes a malpractice-RVU cut, driven by the modifier 25 proposal plus IPCI removal. CMS again questions whether 90-day global packages reflect current care patterns. | −7% overall up to −20.8% work RVU on TKA/THA |
Comment by Sept 14. Start tracking post-op visits and transfers of care with applicable modifiers now — global revaluation is coming |
| Oncology | The OPPS proposal moves 340B-acquired drugs from ASP+6% to ASP−33.4%, roughly a 37% reduction, based on the CMS acquisition-cost survey run Jan 1–Apr 7, 2026. Radiation oncology gains 3% in the CY 2027 PFS, but the AMA PPI survey proposal to bundle radiation oncology practice expense with diagnostic radiology carries a potential 40% reduction in PE/hour. | ASP −33.4% on 340B radiation oncology +3% |
Community oncology should comment on both. Re-price 340B-competitive service lines now |
| Radiology | Site-neutral payment expands: the site-specific PFS-equivalent rate would apply to certain non-contrast imaging in excepted off-campus provider-based departments. The 2.5% efficiency adjustment hits roughly 7,700 procedural and diagnostic codes. Interventional radiology gains 3%. | +3% IR; site-neutral extends to non-contrast imaging | Independent imaging centers gain relative position — revisit hospital-outpatient referral leakage assumptions |
| Neurology | Projected +1% on top of statutory conversion factor changes. Neurology’s E/M-heavy mix shelters it from the efficiency adjustment, which exempts E/M, care management, behavioral health, new codes, and telehealth-list services. | ~+1% | Maximize G2211 usage — the 16% modifier conversion favors longitudinal cognitive specialties |
| Mental / Behavioral Health | Structurally advantaged in 2027: behavioral health services are exempt from the 2.5% efficiency adjustment, and the new APCM behavioral health add-ons (G0568–G0570) create a billable pathway to layer CoCM/BHI onto primary care panels. Offsetting risk: the ABA code set undergoes its largest revision since 2019 effective Jan 1, 2027 — six new codes, all eight Category I descriptors revised, both Category III codes deleted. | Exempt from −2.5% | ABA providers: renegotiate contracted rates in Q4 2026 against the new descriptors |
| Gastroenterology | The site-of-service split continues: office-based procedures are seeing reimbursement increases while the same services in an HOPD or ASC are seeing decreases. ACG has flagged payer downcoding as an emerging 2026 threat alongside the payment shifts. | Office up / facility down | Model the office-vs-ASC differential per procedure; audit for downcoded E/M on the same claims |
Every specialty impact percentage above is a proposed CY 2027 figure with a September 14 comment deadline. And because the ±5% practice expense stabilizer compresses year-one movement, the published 2027 tables understate where several specialties land once the two-year IPCI transition completes. If you are budgeting from the 2027 column alone, you are budgeting the floor.
Ten moves for the week of August 14, 2026 — each one tied directly to something in this issue.